Literature DB >> 20046761

Antimicrobial studies on extracts of four species of stachys.

M Saeedi1, K Morteza-Semnani, M R Mahdavi, F Rahimi.   

Abstract

The antimicrobial activity of the methanol extracts of the dried flowering aerial parts of Stachys byzantina, S. inflata, S. lavandulifolia and S. laxa (Labiatae) were studied using the disc diffusion method and determination of minimum inhibitory concentration (MIC) values against Staphylococcus aureus, Streptococcus sanguis, Escherichia coli, Pseudomonas aeroginosa, Klebsiella pneumoniae, Aspergilus niger and Candida albicans. The extracts of plants exhibited concentration-dependent antibacterial activity against the bacteria tested. The extracts were more active against Gram-positive microorganisms. The extracts, however, did not show any antifungal activity.

Entities:  

Keywords:  Antimicrobial; MIC; Stachys; extract

Year:  2008        PMID: 20046761      PMCID: PMC2792521          DOI: 10.4103/0250-474X.43021

Source DB:  PubMed          Journal:  Indian J Pharm Sci        ISSN: 0250-474X            Impact factor:   0.975


The sub cosmopolitan genus Stachys compromises more than 270 species and is justifiably considered as one of the largest genera of the Labiatae1. The genus Stachys includes 34 species in Iran2. Phytochemical investigations of Stachys species have shown the occurrence of flavonoids, diterpenes, phenyl ethanoid glycosides and saponins3. Plants of this genus have long been applied to treat genital tumors, sclerosis of the spleen, inflammatory tumors and cancerous ulcers4. S. byzantina C. Koch. (syn. S. lanata Jacq.), S. inflata Benth., S. lavandulifolia Vahl and S. laxa Boiss. and Buhse are aromatic plants, which grow in Azerbaijan, Golestan, Khorasan, Mazandaran and Tehran provinces of Iran5. A bibliographical survey showed that there were no reports on the antimicrobial activity of these species. In continuation of studies of Iranian species of the Labiatae family, we have had occasion to investigate the antimicrobial activity of S. byzantina, S. inflata, S. lavandulifolia and S. laxa. The flowering aerial parts of S. byzantina, S. inflata, S. lavandulifolia and S. laxa were collected in May 2004 from the suburb of Behshahr, Mazandaran province, North of Iran and identified at the Department of Botany, Research Center of Natural Resources of Mazandaran). Voucher specimens (herbarium No. 151, 152, 154 and 155) were deposited in the Herbarium of the Department of Botany, Research Center of Natural Resources of Mazandaran. Dried plant materials were ground to fine powder. One hundred grams of the each powders were extracted twice with methanol. The extacts were evaporated to dryness at 40°, and stored in 4°. Staphylococcus aureus PTCC 1112, Streptococcus sanguis PTCC 1449, Escherichia coli PTCC 1330, Pseudomonas aeroginosa PTCC 1074, Klebsiella pneumoniae PTCC 1053, Aspergilus niger PTCC 5011 and Candida albicans PTCC 5027 were used for testing the antimicrobial activity. In vitro antimicrobial studies were carried out by the disc diffusion method and minimum inhibitory concentration (MIC) values were determined against test microorganisms6. In the disc diffusion method, extracts were dissolved in methanol and applied to a 6 mm diameter paper disc. The extracts were tested at 10, 50, 100, 250, 500, 750 and 1000 μg/disc. Inhibition zone diameters were measured after 24 h. Gentamicin (50 μg/disc), amikacin (3 μg/disc) and amphotericin B (100 μg/disc, Sigma) were used as positive controls. MICs were determined by the dilution method at concentrations of 10 μg/ml to 25 mg/ml of culture medium6. Gentamicin (2 mg/ml) and amphotericin B (100 μg/ml) were used as positive controls. The yield of methanol extracts of Stachys byzantina, S. inflata, S. lavandulifolia and S. laxa was 14.1%, 14.3%, 10.1% and 10.6% w/w, respectively. Tables 1 and 2 gives a summary of the results of the antimicrobial effects and MICs of Stachys species investigated. The methanol extracts of the dried flowering aerial parts of S. byzantina, S. inflata, S. lavandulifolia and S. laxa exhibited concentration-dependent antibacterial activity against bacteria tested. The methanol extracts were more active against Gram-positive microorganisms (Streptococcus sanguis and Staphylococcus aureus ). The extracts, however, did not show antifungal activity.
TABLE 1

ANTIMICROBIAL ACTIVITY OF THE METHANOL EXTRACTS OF STACHYS BYZANTINA, S. INFLATA, S. LAVANDULIFOLIA AND S. LAXA*

SampleCon. (μg/disc)Diameter of zone of inhibition (mm)

Bacteria

S. aureus (G +)S. sanguis (G +)E. coli (G -)P. aeroginosa (G -)K. pneumoniae (G -)
S. byzantina10-----
50-8.7---
1008.610.18.5--
2509.611.79.5-8.8
50010.912.711.1-10.1
75012.213.813.38.811.3
100013.415.014.510.213.4
S. inflata10-----
50-----
100-----
2508.38.6-9.08.7
5009.49.88.810.29.5
75010.811.29.611.310.7
100011.912.410.712.711.7
S. lavandulifolia10-----
50-8.6---
100-9.5--8.5
250-10.98.58.69.3
5008.611.79.59.710.9
7509.513.510.610.911.8
100011.615.312.112.412.9
S. laxa10-----
50-----
1008.6----
25010.08.6-8.5-
50011.510.0-9.88.5
75013.211.3-11.610.1
100014.213.4-12.612.2
Gentamicin5037.324.031.631.028.0
Amikacin324.919.923.815.818.0
Amphotericin B100-----

Zone of inhibition, including the diameter of the filter paper disc (6 mm); mean value of eight independent experiments; gentamicin, amikacin and amphotericin B were used as positive controls; - no inhibition.

TABLE 2

MINIMUM INHIBITORY CONCENTRATION (MIC) OF STACHYS BYZANTINA, S. INFLATA, S. LAVANDULIFOLIA AND S. LAXA*

SampleMIC (mg/ml)

Bacteria

S. aureus (G +)S. sanguis (G +)E. coli (G -)P. aeroginosa (G -)K. pneumoniae (G -)
S. byzantina1010254040
S. inflata1010404040
S. lavandulifolia4010252525
S. laxa1025-4040

All determinations were done in triplicate; gentamicin (2 mg/ml) and amphotericin B (100 μg/ml) were used as positive controls

ANTIMICROBIAL ACTIVITY OF THE METHANOL EXTRACTS OF STACHYS BYZANTINA, S. INFLATA, S. LAVANDULIFOLIA AND S. LAXA* Zone of inhibition, including the diameter of the filter paper disc (6 mm); mean value of eight independent experiments; gentamicin, amikacin and amphotericin B were used as positive controls; - no inhibition. MINIMUM INHIBITORY CONCENTRATION (MIC) OF STACHYS BYZANTINA, S. INFLATA, S. LAVANDULIFOLIA AND S. LAXA* All determinations were done in triplicate; gentamicin (2 mg/ml) and amphotericin B (100 μg/ml) were used as positive controls In 2004 and 2005, the antimicrobial activity of some endemic Stachys species including S. sivasica, S. anamurensis, S. cydnia, S. aleurites and S. pinardii was reported; the methanol extracts of Stachys L. were effective only against bacteria tested78. In 2005, essential oils and ethanol extracts from the leaves and/or roots of 35 medicinal plants commonly used in Brazil were screened for antiCandida albicans activity; essential oils from 13 plants including S. byzantina showed anti-Candida activity; the ethanol extract was not effective at any of the concentrations tested9. In the present study, the results concluded that the methanol extracts of these plants have a potential as source of antibacterial agent of natural origin. Preliminary phytochemical studies showed that the aerial parts of the genus Stachys contain flavonoids. Flavonoids may be responsible for their antibacterial activity.
  4 in total

1.  Composition and antibacterial activity of the essential oils of Stachys candida and S. chrysantha from southern Greece.

Authors:  H D Skaltsa; D M Lazari; I B Chinou; A E Loukis
Journal:  Planta Med       Date:  1999-04       Impact factor: 3.352

2.  A chemotaxonomic investigation of volatile constituents in Stachys subsect. Swainsonianeae (Labiatae).

Authors:  H D Skaltsa; A Mavrommati; T Constantinidis
Journal:  Phytochemistry       Date:  2001-05       Impact factor: 4.072

3.  Anti-Candida activity of Brazilian medicinal plants.

Authors:  Marta Cristina Teixeira Duarte; Glyn Mara Figueira; Adilson Sartoratto; Vera Lúcia Garcia Rehder; Camila Delarmelina
Journal:  J Ethnopharmacol       Date:  2005-01-05       Impact factor: 4.360

4.  Phytochemical investigation and anti-inflammatory activity of aerial parts of Stachys byzanthina C. Koch.

Authors:  Mahnaz Khanavi; Mohammad Sharifzadeh; Abbas Hadjiakhoondi; Abbas Shafiee
Journal:  J Ethnopharmacol       Date:  2005-03-21       Impact factor: 4.360

  4 in total
  6 in total

1.  The antimicrobial and antibiofilm effects of three herbal extracts on Streptococcus mutans compared with Chlorhexidine 0.2% (in vitro study).

Authors:  Aida Mehdipour; Azita Ehsani; Nasrin Samadi; Marzieh Ehsani; Negar Sharifinejad
Journal:  J Med Life       Date:  2022-04

2.  Cytotoxic activity of some medicinal plants from hamedan district of iran.

Authors:  Sahar Behzad; Atefeh Pirani; Mahmoud Mosaddegh
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

3.  Evaluation, prediction and optimization the ultrasound-assisted extraction method using response surface methodology: antioxidant and biological properties of Stachys parviflora L.

Authors:  Davoud Salar Bashi; Samaneh Attaran Dowom; Bibi Sedigheh Fazly Bazzaz; Farhad Khanzadeh; Vahid Soheili; Ali Mohammadpour
Journal:  Iran J Basic Med Sci       Date:  2016-05       Impact factor: 2.699

4.  New Rare Ent-Clerodane Diterpene Peroxides from Egyptian Mountain Tea (Qourtom) and Its Chemosystem as Herbal Remedies and Phytonutrients Agents.

Authors:  Taha A Hussien; Ahmed A Mahmoud; Naglaa S Mohamed; Abdelaaty A Shahat; Hesham R El-Seedi; Mohamed-Elamir F Hegazy
Journal:  Molecules       Date:  2020-05-06       Impact factor: 4.411

5.  Phytochemical Analysis and Biological Activity of Three Stachys Species (Lamiaceae) from Romania.

Authors:  Diana Ionela Stegăruș; Ecaterina Lengyel; George Florian Apostolescu; Oana Romina Botoran; Corneliu Tanase
Journal:  Plants (Basel)       Date:  2021-12-09

6.  Effect of Echinophora platyloba, Stachys lavandulifolia, and Eucalyptus camaldulensis plants on Trichomonas vaginalis growth in vitro.

Authors:  Hossein Ali Youse; Afsaneh Kazemian; Manijeh Sereshti; Elham Rahmanikhoh; Elham Ahmadinia; Mahmood Rafaian; Reza Maghsoodi; Hossein Y Darani
Journal:  Adv Biomed Res       Date:  2012-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.